| |
| |
|
| Insider
Information: |
Cooper Jeffrey H |
| Relationship: |
SVP, Chief Financial O... |
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
41,089 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,641,718 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
41,089 |
|
|
| Total
Value |
$3,641,718 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
SVP, Chief Financial O... |
2012-05-14 |
41,089 |
2006-02-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2012-05-14 |
4 |
AS |
$38.09 |
$961,717 |
D/D |
(25,250) |
41,089 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2012-05-14 |
4 |
OE |
$14.39 |
$591,128 |
D/D |
25,250 |
66,339 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2012-04-30 |
4 |
A |
$19.35 |
$19,056 |
D/D |
985 |
41,089 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2012-02-24 |
4 |
S |
$35.07 |
$2,911,989 |
D/D |
(83,036) |
40,104 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2012-02-24 |
4 |
OE |
$14.39 |
$1,541,801 |
D/D |
83,036 |
123,140 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2012-01-03 |
4 |
AS |
$34.75 |
$86,880 |
D/D |
(2,500) |
40,104 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2012-01-03 |
4 |
OE |
$14.39 |
$35,975 |
D/D |
2,500 |
42,604 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2011-11-01 |
4 |
AS |
$33.26 |
$83,145 |
D/D |
(2,500) |
40,104 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2011-11-01 |
4 |
OE |
$14.39 |
$35,975 |
D/D |
2,500 |
42,604 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2011-10-31 |
4 |
A |
$13.23 |
$3,016 |
D/D |
228 |
40,104 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2011-10-10 |
4 |
AS |
$34.00 |
$624,886 |
D/D |
(18,379) |
39,876 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2011-10-10 |
4 |
OE |
$17.54 |
$322,368 |
D/D |
18,379 |
58,255 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2011-09-28 |
4 |
AS |
$32.00 |
$588,128 |
D/D |
(18,379) |
39,876 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2011-09-28 |
4 |
OE |
$17.54 |
$322,368 |
D/D |
18,379 |
58,255 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2011-09-01 |
4 |
AS |
$29.41 |
$73,513 |
D/D |
(2,500) |
39,876 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2011-09-01 |
4 |
OE |
$14.39 |
$35,975 |
D/D |
2,500 |
42,376 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2011-08-02 |
4 |
S |
$30.47 |
$549,557 |
D/D |
(18,036) |
39,876 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2011-08-02 |
4 |
OE |
$17.33 |
$312,564 |
D/D |
18,036 |
57,912 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2011-07-14 |
4 |
OE |
$17.54 |
$322,350 |
D/D |
18,378 |
58,254 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2011-07-14 |
4 |
AS |
$30.00 |
$551,340 |
D/D |
(18,378) |
39,876 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2011-07-01 |
4 |
AS |
$27.50 |
$68,750 |
D/D |
(2,500) |
39,876 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2011-07-01 |
4 |
OE |
$14.39 |
$35,975 |
D/D |
2,500 |
42,376 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2011-06-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,000 |
39,876 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2011-05-26 |
4 |
AS |
$27.50 |
$481,250 |
D/D |
(17,500) |
37,876 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Chief Financial Officer |
• – – |
2011-05-26 |
4 |
OE |
$14.39 |
$251,825 |
D/D |
17,500 |
55,376 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
